Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis

Wang G. -L.; Liu Y.; Qiu P.; Zhou S. -F.; Xu L. -F.; Wen P.; Wen J. -B.; Xiao X. -Z.

首页> 外文期刊>European review for medical and pharmacological sciences. >Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis

【24h】

Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis

机译：拉米夫定，替比夫定，阿德福韦酯和恩替卡韦治疗失代偿性乙肝病毒相关性肝硬化的成本效益

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: To evaluate the cost-effectiveness of lamivudine (LMV), telbivudine (LdT), adefovir dipivoxil (ADV) and entecavir (ETV) on decompensated hepatitis B virus-related cirrhosis.

机译：目的：评估拉米夫定（LMV），替比夫定（LdT），阿德福韦酯（ADV）和恩替卡韦（ETV）治疗失代偿的乙型肝炎病毒相关性肝硬化的成本效益。

著录项

来源
《European review for medical and pharmacological sciences.》 |2016年第5期|共7页
作者
Wang G. -L.; Liu Y.; Qiu P.; Zhou S. -F.; Xu L. -F.; Wen P.; Wen J. -B.; Xiao X. -Z.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Hepatitis B virus; Lamivudine; Telbivudine; Adefovir Dipivoxil; Entecavir; Cirrhosis;

机译：乙肝病毒;拉米夫定;替比夫定;阿德福韦酯;恩替卡韦;肝硬化;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis [J] . Wang G. -L., Liu Y., Qiu P., European review for medical and pharmacological sciences. . 2016,第5期

机译：拉米夫定，替比夫定，阿德福韦酯和恩替卡韦治疗失代偿性乙肝病毒相关性肝硬化的成本效益
2. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis [J] . LianJ.-S., ZengL.-Y., ChenJ.-Y., World journal of gastroenterology : . 2013,第37期

机译：从头开始使用拉米夫定联合阿德福韦酯和恩替卡韦单药联合治疗乙型肝炎病毒相关的代偿性肝硬化
3. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis [J] . Jiang-Shan Lian, Lin-Yan Zeng, Jian-Yang Chen, World Journal of Gastroenterology . 2013,第37期

机译：从头开始拉米夫定和阿德福韦酯联用 vs 恩替卡韦单药联合治疗乙型肝炎病毒相关的代偿性肝硬化
4. Mathematical modeling based on lamivudine switching to adefovir dipivoxil and to entecavir anti-hepatitis B infection treatment [C] . IEEE 5th International Bio-Inspired Computing: Theories and Applications . 2010

机译：基于拉米夫定转为阿德福韦酯和恩替卡韦抗乙型肝炎感染治疗的数学模型
5. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis [O] . Jiang-Shan Lian, Lin-Yan Zeng, Jian-Yang Chen, 2013

机译：从头开始使用拉米夫定联合阿德福韦酯和恩替卡韦单药联合治疗乙型肝炎病毒相关的代偿性肝硬化
6. Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance [O] . Guiliang Wang, Yan Liu, Ping Qiu, 2015

机译：拉米夫鲁德，左侧鉴定和恩替卡维尔治疗慢性乙型肝炎患者的成本效益分析

Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis

摘要

著录项

相似文献

相关主题

期刊订阅